867 China Medical Systems Breakout / Long IdeaHello Tradingviewians,
CMS has been in a long consolidation to digest lowering growth rates. Additionally it has been under fire by short sellers, alleging CMS of faking revenue numbers.
Should the numbers be genuine, and factors like consistent insider buying suggest it, CMS represents serious val
China Medical System Holdings Ltd
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.09 USD
225.99 M USD
1.04 B USD
1.19 B
About China Medical System Holdings Ltd.
Sector
Industry
CEO
Kong Lam
Website
Headquarters
Shenzhen
Founded
1995
IPO date
Sep 28, 2010
Identifiers
3
ISIN KYG211081248
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. Its products include Plendil, Ursofalk, Deanxit, Xinhuosu, Salofalk, BIOFLOR, Augentropfen Stulln Mono, Hirudoid, Combizym, Tanshinone Capsules, Yinuoshu, Nuodikang Capsules, Xidakang, Ganfule Capsules, Imdur, Parlodel, Elcitonin, Lamisil, Yinlian Qinggan Granules, MOVICOL. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund UnitsWeight
2.02%
Market value
38.25 M
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units AWeight
1.49%
Market value
9.48 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of CHSYF is 1.35 USD — it has decreased by −11.00% in the past 24 hours. Watch China Medical System Holdings Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange China Medical System Holdings Ltd stocks are traded under the ticker CHSYF.
We've gathered analysts' opinions on China Medical System Holdings Ltd future price: according to them, CHSYF price has a max estimate of 2.34 USD and a min estimate of 1.87 USD. Watch CHSYF chart and read a more detailed China Medical System Holdings Ltd stock forecast: see what analysts think of China Medical System Holdings Ltd and suggest that you do with its stocks.
CHSYF reached its all-time high on Jun 15, 2021 with the price of 2.76 USD, and its all-time low was 0.78 USD and was reached on Jul 9, 2013. View more price dynamics on CHSYF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CHSYF stock is 12.36% volatile and has beta coefficient of 0.75. Track China Medical System Holdings Ltd stock price on the chart and check out the list of the most volatile stocks — is China Medical System Holdings Ltd there?
Today China Medical System Holdings Ltd has the market capitalization of 4.64 B, it has decreased by −0.30% over the last week.
Yes, you can track China Medical System Holdings Ltd financials in yearly and quarterly reports right on TradingView.
China Medical System Holdings Ltd is going to release the next earnings report on Mar 17, 2026. Keep track of upcoming events with our Earnings Calendar.
CHSYF earnings for the last half-year are 0.05 USD per share, whereas the estimation was 0.05 USD, resulting in a 5.19% surprise. The estimated earnings for the next half-year are 0.04 USD per share. See more details about China Medical System Holdings Ltd earnings.
China Medical System Holdings Ltd revenue for the last half-year amounts to 558.48 M USD, despite the estimated figure of 558.38 M USD. In the next half-year revenue is expected to reach 604.77 M USD.
CHSYF net income for the last half-year is 128.75 M USD, while the previous report showed 99.02 M USD of net income which accounts for 30.02% change. Track more China Medical System Holdings Ltd financial stats to get the full picture.
China Medical System Holdings Ltd dividend yield was 3.85% in 2024, and payout ratio reached 40.22%. The year before the numbers were 3.09% and 39.56% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 6.14 K employees. See our rating of the largest employees — is China Medical System Holdings Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. China Medical System Holdings Ltd EBITDA is 264.27 M USD, and current EBITDA margin is 25.58%. See more stats in China Medical System Holdings Ltd financial statements.
Like other stocks, CHSYF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade China Medical System Holdings Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So China Medical System Holdings Ltd technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating China Medical System Holdings Ltd stock shows the sell signal. See more of China Medical System Holdings Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
